Midgard Science
S

Symeres

Groningen, Netherlands symeres.com

From their website, Nov 2026

Work here? Claim this listing

About

Symeres provides integrated small-molecule drug discovery and development services from idea to IND for biopharma clients. It works across chemistry, biology, ADME-Tox, process development, CMC, and GMP manufacturing through connected teams in Europe and North America.

Services

  • Medicinal chemistry

    Runs hit-to-lead, lead optimization, and preclinical candidate selection programs with SAR development, scaffold design, and compound synthesis.

    Assays & in vitro testing

  • Synthetic chemistry

    Provides custom synthesis, building blocks, intermediates, chiral and isotopic compounds, and scalable synthetic routes for discovery programs.

    Assays & in vitro testing

  • Computational chemistry

    Supports design and optimization of small molecules with computational methods integrated into chemistry programs.

  • Speciality chemistry

    Supports chemistry needs for design, synthesis, and optimization of small molecules with specialty chemistry capabilities.

  • In vitro ADME

    Performs in vitro ADME studies including physicochemical profiling, metabolic stability, metabolite profiling, CYP profiling, plasma protein binding, and permeability assays.

    ADME, DMPK & toxicology

  • In vivo PK screening

    Runs rapid in vivo pharmacokinetic screening studies to assess exposure, clearance, bioavailability, half-life, and tissue distribution.

    ADME, DMPK & toxicology

  • Bioassays

    Provides in vitro bioassays and mechanistic profiling for target validation, potency, biomarkers, mechanism of action, and combination studies.

    Assays & in vitro testing

  • Bioinformatics

    Analyzes biological data to support biomarker discovery, target validation, translational research, patient selection, and mechanism-of-action interpretation.

  • Drug delivery

    Designs and develops lipid and polymer systems to improve solubility, stability, and targeted delivery of therapeutics.

  • Polymers

    Designs, synthesizes, characterizes, and scales polymer-based drug delivery systems and polymer-drug conjugates.

  • Lipids

    Designs, synthesizes, and manufactures lipids for nucleic acid delivery and related drug delivery applications.

  • Process development

    Develops scalable, phase-appropriate chemical processes, including route scouting, optimization, flow chemistry, biocatalysis, and chiral separation.

  • Preclinical drug substance manufacturing

    Converts medicinal chemistry routes into reproducible large-scale processes and supplies non-GMP material for preclinical and IND-enabling studies.

    CDMO: development & manufacturing

  • GMP starting materials

    Manufactures GMP starting materials and advanced intermediates for drug substance preparation with batch manufacturing from 10 L to 1,000 L.

    CDMO: development & manufacturing

  • GMP manufacturing

    Provides GMP manufacturing of drug substances, APIs, and intermediates for preclinical development through clinical supply.

    CDMO: development & manufacturing

  • Clinical formulation development and analytical services

    Provides formulation and analytical support for complex molecules with regulatory-ready documentation for clinical trial material delivery.

  • Drug product

    Develops clinical drug products such as capsules and tablets to support IND submission and early clinical use.

  • Solid state chemistry

    Supports drug development with solid-state chemistry expertise connected to process development and manufacturing.

  • ADME-Tox

    Provides in vitro ADME-Tox and related DMPK studies for small molecules and other modalities to identify risks early and support IND preparation.

    ADME, DMPK & toxicology

  • Chemistry

    Medicinal, computational, synthetic, and specialty chemistry for design, synthesis, and optimization of small molecules, including SAR development, structure-based design, parallel synthesis, and route optimization.

    Assays & in vitro testing

  • ADME

    In vitro and in vivo ADME studies to define pharmacokinetic and metabolic profiles and support candidate selection.

    ADME, DMPK & toxicology

  • Biology

    Assays for target validation, potency, biomarkers, and mechanism of action studies using in vitro enzymatic and cell-based systems with bioinformatics support.

    Assays & in vitro testing

  • Preclinical

    Support from candidate selection through IND/IMPD with regulatory-ready data and documentation.

  • Formulation and analytical development

    Clinical formulation development, analytical development, analytical testing, stability studies, and clinical trial material manufacturing.

  • Spray Drying

    Spray drying capability for formulation development and solubility optimization, including amorphous solid dispersions and particle engineering.

  • In vitro toxicology

    In vitro toxicology services as part of drug discovery support.

    ADME, DMPK & toxicology

Lead time
Fast turnaround

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · ADC · Peptide · Oligonucleotide · mRNA · ADME · In vivo · PK/PD · Analytical development · Toxicology · ADCs · Small molecules
1 moreProcess development
Capacity
600+ scientists · 9 global sites · Batch manufacturing from 10 L to 1,000 L · 2–250 g · Grams to kilograms · >260 well-characterized tumor cell lines · More than 270 annotated cell lines · 10 L to 1,000 L batch manufacturing capabilities · Laboratory-scale spray drying · Pilot-scale spray drying
Offers
Custom synthesis
Scales
Gram · Kilogram
Data supplied
LC-MS

Equipment

  • LC-MS/MS
  • UPLC-HR/MS
  • LC-HR/MS
  • qPCR
  • ELISA
  • DILIscope
  • GPC
  • SEC
  • TFF

Materials

  • Insect cells
  • Primary human cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • AAALACSelf-reported

    Scope: in vivo PK screening facilities

Company

Type
CRO
Team
600+ scientists

Locations

Address
1002 Eastpark Blvd Cranbury, NJ 08512 United States
Sites
Netherlands, Netherlands · Finland, Finland · Czech Republic, Czech Republic · Europe, Europe · North America, North America · Nijmegen, The Netherlands · Breda, The Netherlands · Cranbury, NJ, USA
Serves
Europe, North America, transatlantic

Contacts

Public records

Parent company
Symeres B.V. · NL GLEIF
FDA drug establishment registration
3004153149 · API MANUFACTURE source

Similar labs

Work here? Claim this listing